Proctitis ulcerosa activa y refractaria: Una puesta al día

Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine the factors...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: CASELLI M,GINO, PINEDO M,GEORGE, ZÚÑIGA D,ÁLVARO, ÁLVAREZ L,MANUEL
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2010
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000100016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872010000100016
record_format dspace
spelling oai:scielo:S0034-988720100001000162010-05-10Proctitis ulcerosa activa y refractaria: Una puesta al díaCASELLI M,GINOPINEDO M,GEORGEZÚÑIGA D,ÁLVAROÁLVAREZ L,MANUEL Colitis ulcerative meselamine proctitis Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine the factors that determine the extent of involvement. The goals of therapy in UP are to induce and maintain remission of symptoms and disease. Topical treatment with 5-aminosalicylates (5-ASA) is the treatment of choice to induce remission. In the maintenance phase, long-term follow up studies suggest that treatment with 5-ASA is better than placebo, to maintain the disease inactive. For those patients that do not respond to treatment with topical 5-ASA or have a moderate to severe disease, there are additional therapies such as oral 5-ASA, topical or systemic corticosteroids, immunomodulators, biological therapies (Infliximab) and cyclosporine. Surgery is seldom needed.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.138 n.1 20102010-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000100016es10.4067/S0034-98872010000100016
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Colitis
ulcerative
meselamine
proctitis
spellingShingle Colitis
ulcerative
meselamine
proctitis
CASELLI M,GINO
PINEDO M,GEORGE
ZÚÑIGA D,ÁLVARO
ÁLVAREZ L,MANUEL
Proctitis ulcerosa activa y refractaria: Una puesta al día
description Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine the factors that determine the extent of involvement. The goals of therapy in UP are to induce and maintain remission of symptoms and disease. Topical treatment with 5-aminosalicylates (5-ASA) is the treatment of choice to induce remission. In the maintenance phase, long-term follow up studies suggest that treatment with 5-ASA is better than placebo, to maintain the disease inactive. For those patients that do not respond to treatment with topical 5-ASA or have a moderate to severe disease, there are additional therapies such as oral 5-ASA, topical or systemic corticosteroids, immunomodulators, biological therapies (Infliximab) and cyclosporine. Surgery is seldom needed.
author CASELLI M,GINO
PINEDO M,GEORGE
ZÚÑIGA D,ÁLVARO
ÁLVAREZ L,MANUEL
author_facet CASELLI M,GINO
PINEDO M,GEORGE
ZÚÑIGA D,ÁLVARO
ÁLVAREZ L,MANUEL
author_sort CASELLI M,GINO
title Proctitis ulcerosa activa y refractaria: Una puesta al día
title_short Proctitis ulcerosa activa y refractaria: Una puesta al día
title_full Proctitis ulcerosa activa y refractaria: Una puesta al día
title_fullStr Proctitis ulcerosa activa y refractaria: Una puesta al día
title_full_unstemmed Proctitis ulcerosa activa y refractaria: Una puesta al día
title_sort proctitis ulcerosa activa y refractaria: una puesta al día
publisher Sociedad Médica de Santiago
publishDate 2010
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000100016
work_keys_str_mv AT casellimgino proctitisulcerosaactivayrefractariaunapuestaaldia
AT pinedomgeorge proctitisulcerosaactivayrefractariaunapuestaaldia
AT zunigadalvaro proctitisulcerosaactivayrefractariaunapuestaaldia
AT alvarezlmanuel proctitisulcerosaactivayrefractariaunapuestaaldia
_version_ 1718436485629214720